STAAR SURGICAL CO - 8-K Filing

STAAR Surgical reports Q3 2026 net sales of $83.4 million and announces $50 million share repurchase program. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $STAA

Read the full article at SEC EDGAR

More Regulatory news